EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects

Yun-Jing Hou, Xin-Xin Yang, Hong-Xue Meng

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025

DOI: 10.1016/j.bbcan.2025.189335 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Yun-Jing Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Precision Medicine Center, Harbin M…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Mitochondria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 173 Literaturangaben. Gefördert von: Wu Jieping Medical Foundation, National Natural Science Foundation of China, Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumours reprogram pathways that regulate nutrient uptake and metabolism to meet the biosynthetic, bioenergetic, and redox requirements of cancer cells. This phenomenon is known as metabolic reprogramming and is edited by the deletion of oncogenes and the activation of proto-oncogenes. This article highlights the pathological mechanisms associated with metabolic reprogramming in laryngeal cancer (LC), including enhanced glycolysis, tricarboxylic acid cycle, nucleotide synthesis, lipid synthesis and metabolism, and amino acid metabolism, with a special emphasis on glutamine, tryptophan, and arginine metabolism. All these changes are regulated by HPV infection, hypoxia, and metabolic mediators in the tumour microenvironment. We analyzed the function of metabolic reprogramming in the development of drug resistance during standard LC treatment, which is challenging. In addition, we revealed recent advances in targeting metabolic strategies, assessing the strengths and weaknesses of clinical trials and treatment programs to attack resistance. This review summarises some currently important biomarkers and lays the foundation for therapeutic pathways in LC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsMitochondriaHumansTumor MicroenvironmentEnergy MetabolismGlycolysisDrug Resistance, NeoplasmAnimalsCitric Acid Cycle

Stichwörter der Autor:innen

Laryngeal cancer (LC)Metabolic reprogrammingMitochondriaPathological mechanismsTumour microenvironment

Autor:innen und Institutionen

  • Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Precision Medicine Center, Harbin Medical University Cancer Hospital, Harbin, China.
  • Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: menghongxue@hrbm…

Förderung

  • Wu Jieping Medical Foundation
  • National Natural Science Foundation of China
  • Harbin Medical University
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Hou, Y. J., Yang, X. X., & Meng, H. X. (2025). Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189335

Vancouver

Hou YJ, Yang XX, Meng HX. Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189335

BibTeX
@article{Hou2025,
  author = {Hou, Yun-Jing and Yang, Xin-Xin and Meng, Hong-Xue},
  title = {Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  doi = {10.1016/j.bbcan.2025.189335}
}
Kostenlos starten →